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n-3 PUFA have shown potential anti-obesity and insulin-sensitising properties. However, the mechanisms involved are not clearly established.
The aim of the present study was to assess the effects of EPA administration, one of the n-3 PUFA, on body-weight gain and adiposity in rats fed
on a standard or a high-fat (cafeteria) diet. The actions on white adipose tissue lipolysis, apoptosis and on several genes related to obesity and insulin
resistance were also studied. Control and cafeteria-induced overweight male Wistar rats were assigned into two subgroups, one of them daily received
EPA ethyl ester (1 g/kg) for 5 weeks by oral administration. The high-fat diet induced a very significant increase in both body weight and fat mass. Rats
fed with the cafeteria diet and orally treated with EPA showed a marginally lower body-weight gain (P¼0·09), a decrease in food intake (P,0·01) and
an increase in leptin production (P,0·05). EPA administration reduced retroperitoneal adipose tissue weight (P,0·05) which could be secondary to
the inhibition of the adipogenic transcription factor PPARg gene expression (P,0·001), and also to the increase in apoptosis (P,0·05) found in rats
fed with a control diet. TNFa gene expression was significantly increased (P,0·05) by the cafeteria diet, while EPA treatment was able to prevent
(P,0·01) the rise in this inflammatory cytokine. Adiposity-corrected adiponectin plasma levels were increased by EPA. These actions on both TNFa
and adiponectin could explain the beneficial effects of EPA on insulin resistance induced by the cafeteria diet.
Eicosapentaenoic acid: High-fat diets: White adipose tissue: Insulin resistance
n-3 PUFA present in fish oil are known to have numerous
beneficial effects on health (Connor, 2000; Ruxton, 2004),
suggesting important anti-adipogenic properties of EPA-
enriched diets (Raclot et al. 1997). However, other trials
have not observed any effects on body-weight gain and
visc?eral fat after EPA treatment (Kusunoki et al. 2003). In
this context, previous studies by our group in primary cultured
rat adipocytes (Perez-Matute et al. 2005) and by others in
3T3-L1 cells (Murata et al. 2000) demonstrated that EPA
was able to stimulate leptin gene expression and protein
secretion. These data suggest potential anti-obesity effects of
EPA in vivo since leptin is a hormone primarily secreted by
white adipose tissue (WAT) involved in the regulation of
body weight and body fat stores via its central actions on
food intake and energy expenditure (Marti & Martinez, 1999).
In order to better elucidate the potential EPA anti-obesity
actions, we analysed the effects of its administration in rats
fed on a standard diet or a high-fat (cafeteria) diet (Moreno-
Aliaga et al. 2002; Perez-Echarri et al. 2005). Our cafeteria-
fed rats constitute a useful model for obesity studies because
a high fat intake is a key factor in the development of obesity
(Lopez et al. 2003).
The mechanisms (alterations of adipogenesis, lipolysis,
apoptosis) involved in these potential anti-obesity actions of
EPA remain unclear. Some studies have suggested that an
inhibition of PPARg gene expression, a transcription factor
with a key role as master regulator of adipogenesis, could
be involved in the potential anti-obesity actions of EPA (Rese-
land et al. 2001). However, controversial data are described
(Chambrier et al. 2002). Furthermore, contradictory results
regarding the lipolytic action of n-3 fatty acids have also
been shown (Rustan et al. 1993; Raclot et al. 1997). On the
other hand, several authors suggested that EPA limits fat
cell trophic growth without modifying the cell number (Par-
rish et al. 1990). However, others have observed a reduction
in cellularity of mice epididymal adipose tissue after treatment
with n-3 PUFA-enriched diets (Ruzickova et al. 2004),
suggesting a possible apoptotic effect of EPA, although this
fact has not been yet addressed. Therefore, the aim of the pre-
sent study was to assess for the first time the direct potential
apoptotic effects of EPA in WAT. In addition, we also
tested EPA effects on WAT lipolysis ex vivo and on adipo-
genic PPARg gene expression.
EPA treatment has also been suggested to improve insulin
resistance in several models of obesity and diabetes in rodents
(Mori et al. 1997, 1999; Nobukata et al. 2000). Obesity has
been associated with an inflammatory state which has been
proposed to be the link with several obesity-associated
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disorders such as insulin resistance, CVD and metabolic syn-
drome (Dandona et al. 2004; Moreno-Aliaga et al. 2005). This
inflammatory state associated with obesity appears to be
predominantly triggered and to reside in adipose tissue
(Wellen & Hotamisligil, 2003). The expression and release
of inflammation-related adipokines generally rises as adipose
tissue expands, except for adiponectin, which has an anti-
inflammatory action (Trayhurn & Wood, 2005). Thus,
plasma adiponectin concentrations are decreased in obesity
and are positively associated with whole-body insulin sensi-
tivity (Stefan et al. 2002). EPA and DHA are well known to
have anti-inflammatory properties (Mori & Beilin, 2004),
and the ability of fish oil to alter cytokine production from
several cell types and reduce pro-inflammatory cytokines has
been described (Calder, 2001; Browning, 2003). However, to
our knowledge there are no data available regarding the poten-
tial anti-inflammatory actions of n-3 fatty acids in adipose
tissue. In order to address this question, in the present study
we analysed the effects of EPA supplementation on the pro-
inflammatory cytokine TNFa gene expression in WAT. In
addition, adiponectin gene expression and protein production
were also studied.
In summary, the present trial provides novel insights into
the mechanisms involved in the anti-adipogenic and insulin-
sensitising actions of EPA on WAT, especially regarding its
effects on apoptosis, TNFa and adiponectin production.
Material and methods
Animals and treatment
Twenty-nine male Wistar rats weighing about 180 g (6 weeks
old) were obtained from the Centre of Applied Pharmacology
(CIFA, Pamplona, Spain). Animals were housed (two or three
per cage) in polycarbonate cages in temperature-controlled
rooms (22 ^ 28C) with a 12 h light–dark cycle, fed a pelleted
chow diet (Rodent Toxicology Diet; B&K Universal,
Aldbrough, Hull, UK) and given deionised water ad libitum
for an adaptation period of 4 d. Rats were then assigned to
two dietary groups for 5 weeks. The control group (n 15)
was fed a standard pelleted chow laboratory diet containing
18 % of energy as protein, 76 % of energy as carbohydrate
and 6 % of energy as lipid by dry weight. The overweight
group (n 14) was fed on a fat-rich hyperenergetic ‘cafeteria’
diet composed of pate´, chips, chocolate, bacon, biscuits and
pelleted diet in a proportion of 2 : 1 : 1 : 1 : 1 : 1 as previously
described (Moreno-Aliaga et al. 2002; Perez-Echarri et al.
2005). The composition was 9 % of energy as protein, 29 %
as carbohydrate and 62 % as lipid by dry weight. The fatty
acid composition of both diets (control and cafeteria) is
showed in Table 1. Both dietary groups were divided into
two new subgroups. One subgroup from each dietary group
received by oral administration EPA ethyl ester (1 g/kg per d)
daily for 5 weeks (control EPA and overweight EPA (CEPA
and OEPA) groups). The other subgroups of rats (control
and overweight) received by oral administration the same
volume of water as previously shown in other studies (Mori
et al. 1997; Kusunoki et al. 2003). These groups of rats with-
out treatment with any other type of fatty acid (such as satu-
rated fatty acids with equal chain length as EPA or oleic
acid) are more likely to be considered as control groups in
our study design. This is because it has been demonstrated
that supplementation with some other fatty acids is able to
modify adiposity and the circulating levels of biochemical
and hormonal markers planned to be determined in the present
study (Mori et al. 1997).
Body weight and food intake were daily recorded. At the
end of the experimental period and after an overnight fast,
rats were killed by decapitation and blood and tissue samples
were collected and kept at 280 8C for subsequent analysis. All
procedures were conducted under protocols approved by the
University Ethics Committee for the use of laboratory animals.
Biochemical measurements
Serum glucose was measured using an autoanalyser (Cobas
Roche Diagnostic, Basel, Switzerland). Plasma insulin and
leptin were assayed by RIA (Linco Research, St Charles,
MO, USA). Adiponectin concentrations in serum were deter-
mined by a Mouse/Rat Adiponectin ELISA kit (B-Bridge
International, Inc., Sunnyvale, CA, USA).
Adipocyte isolation and ex vivo lipolysis
Adipocytes were isolated from retroperitoneal fat pads of male
Wistar rats. The fat pads were minced into pieces in Krebs–
Ringer HEPES buffer (pH 7·4; containing 5 mM-D-glucose,
2 % bovine serum albumin, 135 mM-NaCl, 2·2 mM-
CaCl2.2H2O, 1·25 mM-MgSO4.7H2O, 0·45 mM-KH2PO4,
2·17 mM-Na2HPO4 and 10 mM-HEPES). Adipose tissue frag-
ments were digested in the same buffer with type I collagenase
(1·25 mg/ml per 0·5 g tissue; Worthington, Lakewood, NJ,
USA) at 37 8C with gentle shaking at sixty cycles/min for
30 min. The resulting cell suspension was diluted in HEPES-
phosphate buffer and the isolated adipocytes were then separ-
ated from the undigested tissue by filtration through a 400mm
nylon mesh and washed three times. Ex vivo lipolysis was
performed in isolated adipocytes according to Campion &
Martı´nez (2004). Results were expressed as mmol glycerol
released per 100 mg total lipids after 90 min of incubation in
Krebs–Ringer buffer.
Detection of white adipose tissue apoptosis
Apoptotic cell death was measured by using the Cell
Death Detection ELISAPLUS kit (Boehringer Mannheim
Table 1. Fatty acid composition (%) of control and cafeteria diets
Fatty acid Control diet Cafeteria diet
12 : 0 (Lauric) 0·00 0·00
14 : 0 (Myristic) 0·76 0·70
16 : 0 (Palmitic) 14·42 29·82
16 : 1n-7 (Palmitoleic) 0·76 1·75
18 : 0 (Stearic) 3·19 13·45
18 : 1n-9 (Oleic) 22·91 40·80
18 : 2n-6 (Linoleic) 51·12 12·48
18 : 3n-3 (Linolenic) 5·92 0·22
20 : 0 (Arachidic) 0·00 0·65
20 : 4n-6 (Arachidonic) 0·00 0·11
20 : 5n-3 (Eicosapentaenoic) 0·00 0·00
22 : 1n-9 (Erucic) 0·83 0·03
22 : 6n-3 (Docosahexaenoic) 0·09 0·00
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Biochemicals, Indianapolis, IN, USA). This is a photometric
enzyme-immunoassay for quantitative in vitro determination
of cytoplasmic histone-associated DNA fragments, which are
generated during apoptosis, using monoclonal antibodies
directed against DNA and histones, respectively. All exper-
imental procedures were carried out on ice. The assay was per-
formed according to the manufacturer’s instructions, reading
absorbance at 405 nm and subtracting absorbance at 490 nm
for each well (A405–A490). Data represent average values
from double absorbance measurements of each sample and
were calculated subtracting the background value of the
immunoassay from each value (Margareto et al. 2000).
Gene expression levels in white adipose tissue
Epididymal adipose tissue mRNA expression levels were
determined by Northern blotting as described by Pe´rez-
Matute et al. (2003). The leptin cDNA probe was a 388 bp
fragment whereas adiponectin cDNA probe was a 497 bp frag-
ment. They were kindly provided by Dr Charles Mobbs
(Mount Sinai School of Medicine, New York), which is grate-
fully acknowledged. The PPARg2 cDNA probe (Genbank
accession number Y12882) was a 570 bp fragment of rat
cDNA, and the primers used were 50-TCTGATTATGGGTG-
AAACTC-30 (sense 43–62) and 50-TTTCTACTCTTTTTGT-
GGATC-30 (antisense 592–612). A 320 bp TNFa DNA frag-
ment was prepared by the PCR with primers corresponding
to the nucleotides 923–942 (50-CCCCATTACTCTGACC-
CCTT-30) and 1223–1242 (50-AGGCCTGAGACATCTT-
CAGC-30) of rat TNFa cDNA (Genbank accession number
AF329987) (Kawaguchi et al. 2003). The 18S ribosomal
probe was obtained from Ambion (Austin, TX, USA).
mRNA expression levels were normalised with respect to
this 18S ribosomal signal. Signals were quantified using a
Sharp JX-325 densitometric scanner (Sharp Electric, Tokyo,
Japan) and the analysis was carried out with the software Ima-
geMastere (Pharmacia Biotech, Uppsala, Sweden).
Statistical analysis
Results are given as mean values with their standard errors.
Statistical differences and interactions were evaluated with a
factorial two-way ANOVA (diet £ EPA treatment). When
statistically significant differences resulted at the interaction
level, a Student’s t test was carried out to compare the effects
of each treatment (GraphPad Prism; GraphPad Software Inc.,
San Diego, CA, USA). Differences were considered as statisti-
cally significant at P,0·05.
Results
Effects on body-weight gain and food intake
High-fat-fed rats showed a significant increase in both final
body weight (P,0·001) and body-weight gain (P,0·001) at
the end of the experimental trial as compared with control
animals (Fig. 1). The administration of EPA (1 g/kg) did not
significantly alter body-weight gain, although a marginal
decrease (P¼0·09) could be observed after EPA treatment in
the group of rats fed with the cafeteria diet (OEPA).
Energy intake was measured in order to find out if the
differences showed in body-weight evolution could be related
to differences in food intake. Overweight rats (fed with a high-
fat diet) showed a significant increase in their food intake
(P,0·001), which was reduced in part by EPA treatment
(P,0·01). Feed efficiency, the weight gain:energy consumed
ratio, was significantly decreased (P,0·001) in all groups
receiving the high-fat diet as compared with the control
group. However, EPA treatment did not modify this parameter
(Table 2).
Effects on white adipose tissue weights
Wet weights (g) of WAT from overweight rats were signifi-
cantly higher than in lean animals (P,0·001). Daily adminis-
tration of EPA produced a significant reduction (P,0·05) in
retroperitonal adipose tissue weight. Indeed, EPA treatment
showed a tendency (non-significant) to decrease the weight
of all the fat pads, but only in the group of animals fed with
a standard diet (Table 2).
Regarding brown adipose tissue, animals fed with the cafe-
teria diet showed an increase in brown fat (P,0·001) as com-
pared with control rats, while the administration of EPA did
not modify the size of this fat depot (Table 2).
Effects on plasma biochemical parameters
Neither the cafeteria diet nor EPA treatment modified glucose
plasma levels; however, a slight increase was observed after
the consumption of the high-fat diet (P¼0·08). EPA treatment
induced a significant reduction (P,0·05) in both insulin
plasma levels and the homeostasis model assessment
(HOMA) index, an index of insulin resistance, suggesting
that EPA is able to partially prevent the development of
insulin resistance induced in a non-significant manner by the
cafeteria diet (Table 3).
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Fig. 1. Effects of EPA (35 d treatment) on the growth curve in rats: control
rats (n 8; –†–), control rats treated with EPA (1 g/kg; n 7; –W–), overweight
rats (high-fat-diet; n 7; –P–) and overweight rats treated with EPA (1 g/kg;
n 7; –L–). Body weight was daily recorded. Data are means, with standard
errors represented by vertical bars. Statistical analysis was by two-way
ANOVA; the effect of diet was significant (P,0·001).
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Effects on retroperitoneal white adipose tissue apoptosis
No differences in the relative apoptosis rate were observed in
overweight rats as compared with the basal apoptosis of the
control rats. EPA treatment induced a marked increase
(P,0·05) in the levels of histone-associated DNA oligonu-
cleosomal fragments, a characteristic marker of apoptosis in
the group of animals fed with the standard diet but not in
the high-fat-fed rats (Fig. 2).
Effects on ex vivo lipolysis
High-fat-diet feeding caused a significant decrease (P,0·05)
in isoproterenol-stimulated lipolytic response in both EPA-
treated and untreated rats (Fig. 3). EPA treatment, however,
did not affect either basal lipolysis (data not shown) or isopro-
terenol-induced lipolysis (Fig. 3).
Effects on leptin circulating levels and gene expression
Regarding leptin circulating levels, a significant interaction
(P,0·01) was obtained between diet and EPA treatment. As
expected, leptin levels were significantly higher (P,0·05) in
the cafeteria-fed group as compared with control animals.
EPA treatment significantly decreased leptin circulating
levels (P,0·01) in the group of animals fed on a standard
diet while a significant increase (P,0·05) was observed in
overweight rats treated with the fatty acid (Fig. 4 (A)).
When leptin serum concentrations were corrected for adiposity
(leptin per g WAT), which was estimated by the sum of all fat
depots collected (see Table 2), a significant decrease (P,0·05)
was observed in the group of control animals treated with
EPA. On the contrary, EPA caused a significant elevation of
leptin production levels (P,0·01) in the high-fat-fed rats
(Fig. 4 (B)). Similarly, leptin gene expression in epididymal
fat showed the same pattern as circulating levels (Fig. 4 (C)).
Effects on adiponectin circulating levels and gene expression
Regarding adiponectin, cafeteria-diet feeding significantly
increased adiponectin circulating levels (P,0·001); however,
EPA treatment did not affect the circulating levels of this adi-
pokine (Fig. 5 (A)). When adiponectin concentrations were
corrected for adiposity (adiponectin per g WAT), a marginally
non-significant decrease (P¼0·07) was observed in the cafe-
teria-fed group. Furthermore, EPA treatment induced a signifi-
cant increase (P,0·05) in adiponectin concentrations per g
WAT (Fig. 5 (B)).
Northern blot analysis revealed three mRNA bands for adi-
ponectin in rats (Hu et al. 1996). In agreement with the
observed levels of serum adiponectin, an increase in adiponec-
tin gene expression in WAT was also observed after EPA
treatment (Fig. 5 (C)).
Several studies have suggested that there is a strong
relationship between low adiponectin levels and insulin resist-
ance (Hotta et al. 2001). In fact, our data showed an inverse
relationship between serum adiponectin levels corrected for
adiposity and HOMA index (r 20·43; P,0·05).Ta
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Effects on white adipose tissue peroxisome proliferator-
activated receptor-g and tumour necrosis factor-a gene
expression
The expression of the adipogenic factor PPARg was signifi-
cantly (P,0·001) decreased by EPA treatment in both control
and cafeteria-fed animals (Figs. 6 (A) and (B)).
As is observed in Figs. 6 (C) and (D), TNFa gene
expression was significantly stimulated (P,0·05) by cafe-
teria-diet feeding. EPA treatment was able to prevent
(P,0·01) the rise in the expression of this inflammatory cyto-
kine induced by the high-fat diet.
Discussion
Animals fed with a high-energy-yielding diet during 35 d
exhibited a significant increase in body-weight gain. EPA
treatment, however, was not able to prevent this increase
induced by the high-fat diet, although a moderate lower
body-weight gain was observed in the group of animals fed
with the high-fat diet and orally treated with EPA. These
results are in agreement with those from Kusunoki et al.
(2003) who did not observe any significant effect of EPA
treatment (concentrations from 0·3 to 1 g/kg) on body-weight
gain in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Energy intake was measured in order to find out if the moder-
ate differences showed in body-weight evolution could be
related to differences in food intake. As in previous studies,
animals fed with the high-fat diet showed an increase in
food intake in comparison with the control group, probably
because palatability is the predominant force driving the
hyperphagia in cafeteria-fed animals (Berraondo et al. 2000;
Margareto et al. 2001). Interestingly, EPA treatment was
able to decrease food intake, but only in the group of animals
fed on the cafeteria diet (OEPA). It is well known that rising
concentrations of leptin generate a signal to reduce food intake
and increase energy expenditure (Havel, 2004). Taking into
account this role of leptin in body-weight regulation, it
could be suggested that the EPA-induced increase in leptin
production specifically observed in the cafeteria-fed rats
could explain the decrease in food intake observed in this
group of animals. Peyron-Caso et al. (2002) also described
an increase in leptin concentrations in rats fed an n-3
PUFA-enriched diet. In addition, our previous studies in pri-
mary cultured rat adipocytes also demonstrated a stimulatory
action of EPA on leptin production (Perez-Matute et al.
2005). However, other studies showed an inhibitory action
of this fatty acid on leptin (Raclot et al. 1997; Reseland
et al. 2001). These conflicting results could be due to the
observations that the effects of n-3 PUFA on leptin are depen-
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Fig. 2. Effects of EPA on apoptosis in white adipose tissue of control and
overweight rats. Data are means for at least seven independent animals per
group, with standard errors represented by vertical bars. Statistical analysis
was by two-way ANOVA; the diet £ EPA interaction was significant
(P,0·01). When an interaction was found, comparisons between groups
were analysed by a Student’s t test. *Mean value was significantly different
from that of the control group (P,0·05). CEPA, control EPA; OEPA, over-
weight EPA.
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Fig. 3. Effects of EPA on isoproterenol-induced lipolysis in white adipose tis-
sue from control and overweight-cafeteria rats. Data are means for at least
four independent animals per group, with standard errors represented by ver-
tical bars. Statistical analysis was by two-way ANOVA; the effect of diet was
significant (P,0·05). CEPA, control EPA; OEPA, overweight EPA.
Table 3. Serum glucose, plasma insulin and homeostasis model assessment (HOMA) index in control and eicosapentaenoic acid-treated
lean and overweight rats*
(Mean values with their standard errors)
Control
(n 8)
CEPA
(n 7)
Overweight
(n 7)
OEPA
(n 7) 2 £ 2 ANOVA
Mean SE Mean SE Mean SE Mean SE Diet EPA Diet £ EPA
Glucose (mg/l) 948 27 933 37 1045 35 958 33 P¼0·08 NS NS
Insulin (pM) 161·5 27·0 78·0 5·3 195·8 46·6 138·8 16·4 NS P,0·05 NS
HOMA† 5·4 0·9 2·5 0·08 7·1 1·6 4·8 0·5 NS P,0·05 NS
CEPA, control EPA; OEPA, overweight EPA.
* Data were analysed by two-way ANOVA.
† HOMA ¼ insulin (mUnits) £ glucose (mmol/l)/22·5.
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dent on a number of factors such as diet composition and
energy balance. In this way, the present results showed oppo-
site effects of EPA treatment in control rats in comparison
with the overweight group. Other studies have also observed
differential actions of some anti-obesity treatments (such as
b-adrenergic agonist) on genes related to energy homeostasis
between control and obese animals (Berraondo et al. 2000).
With regard to adiposity, EPA treatment induced a depot-
specific reduction in the weight of retroperitoneal fat, as pre-
viously observed by Raclot et al. (1997). Furthermore, EPA
treatment also induced a moderate reduction in the weight
of all fat depots but only in control animals. Hill et al.
(1993) observed a decrease in all fat depots of adult male
Wistar rats after 6 months of treatment with dietary n-3
PUFA, suggesting that the potential anti-adipogenic actions
of n-3 PUFA are dependent on treatment duration and meta-
bolic status. In this sense, if our EPA treatment lasted more
than 5 weeks, it could be possible to observe a significant
decrease in the weight of all fat depots and not only in the ret-
roperitoneal fat pad. Paradoxically, the lowering effects of
EPA on adiposity contrast with the lack of effects on body-
weight gain observed in control rats. Previous studies have
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found that a fish oil-enriched diet induces greater gain in lean
body mass and a lower gain in fat in comparison with animals
fed with other type of enriched diets (Su & Jones, 1993).
Although we have not performed any body composition
measurements, our data also suggest that EPA treatment
could induce a body composition redistribution, which could
explain that a reduction in adipose tissue weight did not
always mean a decrease in total body weight, as observed in
the present study.
An increase of lipolysis could be a potential mechanism
responsible for the limitation of retroperitoneal fat weight
after EPA treatment. The increase in fat pad weights in
high-fat-fed animals was accompanied by a decrease in the
isoproterenol-induced lipolytic response, as previously
shown (Portillo et al. 1999). The present study demonstrated
a lack of effect of EPA on both basal and isoproterenol-stimu-
lated lipolysis, suggesting that the potential anti-adipogenic
properties of this fatty acid are not mediated by a lipolytic
action in WAT. In addition, our in vitro study in cultured adi-
pocytes also argues against a direct lipolytic action of this
fatty acid (Perez-Matute et al. 2005).
PPARg, a member of the nuclear hormone receptor super-
family, is an important adipogenic transcription factor. Several
articles have described an increase in the expression of this
factor in WAT of high-fat-fed obese animals (Margareto
et al. 2002; Lopez et al. 2003). In the present study, we
have also observed a slight non-significant increase in the
expression of this factor after the cafeteria-diet consumption
without statistical significance. Several studies have reported
the ability of EPA to modulate the expression and activity
of this adipogenic factor, although the results are controver-
sial. Thus, some studies have observed an inhibitory action
of EPA on PPARg (Reseland et al. 2001) while others have
observed an stimulatory effect (Chambrier et al. 2002). Our
data revealed that EPA-treated animals exhibited a decrease
in the adipogenic PPARg gene expression levels, which
could impair the adipogenic process, contributing to the
decrease in WAT weight observed in these animals.
Targeting apoptotic pathways in adipocytes has been pro-
posed as a potential novel treatment for obesity (Nelson-
Dooley et al. 2005). We tested if an increase in apoptosis
could be contributing to the reduced WAT size. Ruzickova
et al. (2004) demonstrated that n-3 PUFA limit diet-induced
obesity in mice by reducing cellularity of adipose tissue and,
although they did not directly measure apoptosis, their data
suggest a potential apoptotic action of EPA. Our data
showed for the first time that an increase in apoptosis is
involved in the more efficient action of EPA on the reduction
of WAT size observed in control rats. Thus, the rise in the
apoptotic cell death rate would decrease adipocyte number
and consequently adipose tissue weight. Finally, we also
observed in the present study that the cafeteria diet strongly
impaired this apoptotic action induced by EPA, suggesting
that EPA-induced apoptosis depends on the nutritional and
metabolic status of animals. Furthermore, the opposite effects
of EPA observed in control and cafeteria-fed rats could be also
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due to the different percentage of EPA in relation to total
lipids supplied by both types of diets. In the present study,
the EPA supplemented by oral administration in rats fed
with the cafeteria diet (62 % of energy as fat) accounts for
2·1 % of the total lipids. However, EPA accounts for a
30·2 % of the total lipids ingested by the rats fed with the con-
trol diet (6 % of energy as fat) and orally treated with EPA.
In this context, recent evidence suggests that the ratio between
different types of fatty acids such as the n-6 and n-3 fatty acids
is an important fact in determining their effects on health
(Simopoulos, 2002; Weiss et al. 2005).
Several studies have suggested that obesity could be an
inflammatory disease (Das, 2001; Ramos et al. 2003). In
this context, several markers of chronic inflammation, such
as TNFa, have been found to be associated with obesity and
insulin resistance (Ramos et al. 2003). In fact, similarly to
our present data, an induction of TNFa mRNA expression
and activity was observed in adipose tissue from different
rodent models of obesity (Hotamisligil et al. 1993; Morin
et al. 1997). Here, we have demonstrated for the first time
that EPA treatment was able to down regulate the increased
adipose TNFa gene expression induced by a high-fat diet.
Although the mechanisms involved in this inhibitory action
have not been yet elucidated, it has been suggested that
EPA could prevent the NF-kB activation (Zhao et al. 2004).
The inflammatory state associated with obesity seems to be
predominantly initiated and to reside in adipose tissue,
although other metabolically key organs may also be involved
during the course of the disease (Wellen & Hotamisligil,
2003). In addition, this inflammatory state associated with
obesity has been proposed to be the link with several obes-
ity-associated disorders such as insulin resistance (Dandona
et al. 2004). Indeed, increased TNFa levels have been associ-
ated with increased insulin resistance in adipose tissue, by
reducing the phosphorylation of insulin receptor sustrate-1
(Hotamisligil, 1999). Therefore, our data lead us to suggest
that the improvement in insulin sensitivity induced by EPA
could be mediated, at least in part, by decreasing the inflam-
mation in the adipose tissue of the overweight rats.
Adiponectin is an anti-inflammatory adipokine with an
important role in insulin sensitivity (Combs et al. 2004).
Thus, hypoadiponectinaemia has been related to the develop-
ment of insulin resistance and cardiovascular risk associated
with obesity (Hotta et al. 2001; Kubota et al. 2002; Kumada
et al. 2003). However, our data showed that levels of circulat-
ing adiponectin were increased in overweight rats fed with the
high-fat diet. Several studies have also shown an increase in
both adiponectin circulating levels and gene expression in
early stages of obesity (11, 15 and 21 d of high-fat-diet con-
sumption) (Li et al. 2002; Lopez et al. 2004; Perez-Echarri
et al. 2005) suggesting that this could be an initial mechanism
in the adaptation to high energy intake. In the present study,
when the levels of circulating adiponectin were corrected for
adiposity, a moderate non-significant decrease was observed
in the untreated cafeteria rats, accompanied by a decrease in
the expression of this adipokine, suggesting an impairment
in adiponectin production processes by the overweight adipo-
cytes. These results suggest that when obesity is more estab-
lished (for example, after 65 d of a high-fat diet as described
by Lopez et al. (2005)) the ability of adipocytes to express
and secrete adiponectin is more strongly impaired. Our data
also suggest that this ability of adipocytes to produce adipo-
nectin was significantly increased by the administration of
EPA, which could contribute to the insulin-sensitising proper-
ties of this fatty acid. Furthermore, a negative relationship was
found in the present study between adiposity-corrected adipo-
nectin plasma levels and the HOMA index which supports
the beneficial effects of EPA supplementation on insulin
sensitivity. A recently published study (Flachs et al. 2006)
has also observed that feeding mice with a high-fat diet
enriched with EPA and DHA leads to elevated systemic con-
centrations of adiponectin, and suggested that this increase
could explain, to some extent, the n-3 EPA antidiabetic
properties.
In summary, our data suggest that EPA supplementation
could help to reduce adiposity through the down regulation
of PPARg and through the increase of apoptosis in WAT.
EPA also exhibited antidiabetic properties which could be
related to its reducing effects on the pro-inflammatory cyto-
kine TNFa mRNA levels in adipose tissue and increasing
the capacity of the adipose tissue to produce the insulin-sensi-
tising adipokine, adiponectin. In addition, the present study
suggests that some EPA actions seem to be dependent on
diet composition and the physiological and metabolic status
of animals, which could be important to take into account
when considering supplementation with n-3-enriched-pro-
ducts.
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